Anoosh Esmaeili, Kachina Behnke‐Hall, Roland Schrewe, Dietmar Schranz
Congenital Heart Disease, Vol.14, No.3, pp. 389-395, 2019, DOI:10.1111/chd.12731
Abstract Aim: The purpose of this study is to describe the special aspects of perimembranous
ventricular septal defects (pmVSD) closure by utilizing Amplatzer Duct Occluder II
(ADO II) devices with a rational request for bigger ADO‐II sizes, based on our experi‐
ence in transcatheter device closure of pmVSD.
Methods and Results: At our institution, placement of an ADO II device was used in
15 patients with pmVSD; the patients’ age ranged between 6 months and 20 years.
The indications for closure were CHF (n = 4), hemodynamically significant shunt
(n = 7), tricuspid regurgitation (n = 3), and high risk for… More >
Login
Register
